Rare diseases
Investigational molecules
Locations
Back to Belgium11 clinical trials in Tournai, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of icotrokinra for adults with moderately to severely active Crohn's disease
BelgiumTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
BelgiumStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
BelgiumStudy on the Effectiveness of 2LPAPI with Interferon Alfa in Clearing Genital HPV Infections in Patients
BelgiumStudy on Preventing Crohn's Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk
BelgiumRandomized trial of standard vs high-dose enoxaparin and sodium chloride for preventing clots in critically ill ICU patients at high risk of thrombosis
BelgiumEvaluation of Upadacitinib for Reducing Ileal Strictures in Patients with Crohn’s Disease
BelgiumTitle: Study of solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety
BelgiumStudy on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination
BelgiumStudy on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn's Disease, or Unclassified Inflammatory Bowel Disease
BelgiumStudy on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on Crohn's disease and ulcerative colitis treatments, evaluating new therapeutic approaches for patients with moderate to severe conditions.
Multiple trials are investigating innovative medications including obefazimod and mirikizumab for improved patient outcomes.
Groundbreaking research into eosinophilic esophagitis treatment options, examining the efficacy of new medications for reducing inflammation and improving symptoms.
Current trials are evaluating solrikitug as a potential treatment option for patients with EoE.
Advanced research in breast cancer treatment, particularly focusing on HER2-negative and estrogen receptor-positive cases in elderly patients.
Studies are exploring personalized treatment approaches combining chemotherapy and hormone therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
